Skip to main content

Building a Best-in-class Urologic Oncology Company

Technologies to better visualize and treat urologic cancers through minimally invasive procedures in the physicians office & hospital

Improving outcomes & patient care

Better visualization to help detect bladder cancer

The i/Blue Imaging System™ small, smart, easier-to-use imaging system for improved visualization of bladder cancer

Precision ablation of prostate cancer

The enCAGE Coil™ radiofrequency focal therapy device for precision ablation of soft tissue is being refined for the treatment of prostate cancer

Adaptable technologies for the office setting

Imagin Medical’s technologies will be adapted to additional minimally invasive surgeries such as laparoscopic surgery

Latest Media

22 August 2022

Imagin Medical Announces Acquisition of the enCAGE Coil™ Precision Ablation System for Prostate Cancer and a New $7.25M Convertible Note to Finance Its Development

Imagin Medical Inc., a urologic oncology company, announces: the acquisition of the enCAGE Coil™ Precision Ablation System for Prostate Cancer from TROD Medical NV, a Belgian company…

26 August 2021

Imagin Medical Secures New $3 Million Convertible Note Financing

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced that it has closed a new Convertible Note offering totaling US$3,000,000…